SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg4/27/2007 2:10:30 AM
  Read Replies (1) of 10280
 
Sepracor "equal weight," target price reduced

[Fine-tuning]

Thursday, April 26, 2007 2:21:12 AM ET
Lehman Brothers

NEW YORK, April 26 (newratings.com) - In a research note published yesterday, analysts at Lehman Brothers reiterate their "equal weight" rating on Sepracor Inc (SEPR.NAS). The target price has been reduced from $57 to $56.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext